Avai Bio, Inc.
corporate_fare Company Profile
Avai Bio, Inc. (OTC:AVAI) is a publicly traded company in the Technology sector. Wiseek has independently scored 6 items for AVAI at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 8/10. Across its 6 most recent items scored 7 or higher, the top rating is 9/10, with 4 rated 8 or above. Recent SEC coverage for AVAI spans 10-Q, 10-K, 8-K.
Recent high-impact activity:
- Avai Bio 10-Q: Going Concern Doubt, $4.35M Working Capital Deficit, $10M Raise Needed
- Avaí Bio Hits Key Milestone: Klotho-Producing Cells Successfully Encapsulated and Secreting
- AVAI Bio Posts $552K Quarterly Loss, Cash Rises to $84K, Going Concern Lingers
- AVAI Bio 10-K Flags Going Concern Doubt, $1.75M Loss, and Material Weaknesses
- AVAI BIO Terminates AI Healthcare Joint Venture with Ainnova Tech
Financial Snapshot
Short Interest & Short Volume
On November 18, 2026, 15.8% of AVAI volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.